Childhood Cancer

You are here

Home » Grants » All grants tagged with "No name"

All grants tagged with "No name"

Targeting splicing in chemoresistant ewing sarcoma
Daniel Frank
Northeast Ohio Medical University
POST Program Grants, Awarded 2025
Utilizing a novel zebrafish model of neuroblastoma to identify mechanisms of tumor regression
Perla Luna-Camacho
University of Mississippi Medical Center
POST Program Grants, Awarded 2025
Exploring the interplay of microbiome, bile acids, immune reconstitution, and clinical outcomes following allogeneic hematopoietic transplantation
Hannah Gulko
Memorial Sloan-Kettering Cancer Center
POST Program Grants, Awarded 2025
Preclinical investigation of ONC206 and PI3K-AKT inhibition for the treatment of medulloblastoma
Isabella Gershon
Emory University
POST Program Grants, Awarded 2025
Designing targeted lipid nanoparticles for CAR T cell generation
Itzel Huerta
University of California, Los Angeles
POST Program Grants, Awarded 2025
Peripheral neuropathy in pediatric germ cell tumor survivors
Ryan Salama
University of Minnesota
POST Program Grants, Awarded 2025
Investigating mechanisms of Inotuzumab resistance in pediatric B-ALL
Martin Rodriguez Alvarado
New York University School of Medicine
POST Program Grants, Awarded 2025
Maximization of oncolytic virotherapy for pediatric brain tumor through inhibition of IDO and BTK
Hailey Garner
Augusta University
POST Program Grants, Awarded 2025
Deciphering the tumor microenvironment in metastatic osteosarcoma for therapeutic benefit
Lester Heredia Gopar
Dana-Farber Cancer Institute
POST Program Grants, Awarded 2025
Treatment of drug-resistant medulloblastoma with RNA translation inhibitors
Simon Kleiner
University of Michigan
POST Program Grants, Awarded 2025

Pages

All childhood cancer types

Featured Hero

Tony Salerno

Tony was diagnosed with neuroblastoma when he was just 2-and-a-half years old. Chemotherapy, surgery, stem cell transplants, and radiation treatments all helped him fight, but also left him with long-term side effects. Despite these, today he is thriving!
Read more »